# Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer

> **NCT00438256** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 50 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** Proton Beam Radiation
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT00438256
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-01-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438256, "Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00438256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*